Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002595334 | SCV003495062 | likely benign | Drash syndrome; Frasier syndrome; Wilms tumor 1; 11p partial monosomy syndrome | 2022-10-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004550417 | SCV004118698 | uncertain significance | WT1-related disorder | 2022-08-31 | criteria provided, single submitter | clinical testing | The WT1 c.246C>A variant is not predicted to result in an amino acid change (p.=). This variant is predicted to introduce a cryptic splice site in exon 1 based on splicing prediction programs (Alamut Visual Plus v.1.6.1). However, computer prediction programs are not equivalent to functional evidence. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.023% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-32456646-G-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |